Royalty Pharma holds the cleaner structural position, with the lead spread across stability and profitability. S&P Global does not offset that deficit through any equally strong structural edge elsewhere. On the market side, Royalty Pharma is in better shape — its trend is intact while S&P Global's trend has broken down. That puts structure and market broadly in agreement — Royalty Pharma's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
The clearest separation starts in stability, but profitability adds another real layer to the result. The overall score gap is 17 points in favour of Royalty Pharma plc.
This pair is matched through long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
The strongest overlap appears in investment intensity and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Neither company combines the stronger profile with the cheaper valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The clearest distance comes from a steadier profile over time.
S&P Global Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
The lead is built on both stability and profitability, making it broader than a single-dimension result.
Break down the RPRX vs SPGI comparison across all dimensions with the full interactive tool.
Explore how RPRX and SPGI each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.